Hemgenix (126-130 kg)
Generic name: etranacogene dezaparvovec
Brand names: Hemgenix (101-105 kg), Hemgenix (106-110 kg), Hemgenix (111-115 kg), Hemgenix (116-120 kg), Hemgenix (121-125 kg),
... show all 16 brands
Drug class: Miscellaneous coagulation modifiers
What is Hemgenix (126-130 kg)?
Hemgenix (126-130 kg) is used to treat a bleeding disorder called Hemophilia B in adults who are receiving preventive treatment for the condition, have recurrent episodes of serious bleeding or have current or previous life-threatening bleeding events.
Hemgenix (126-130 kg) may also be used for purposes not listed in this medication guide.
Hemgenix (126-130 kg) side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Some side effects may occur during or right after the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, unusual bleeding, or swelling in your face.
Common side effects of Hemgenix (126-130 kg) may include:
-
abnormal blood tests;
-
headache;
-
flu-like symptoms;
-
a reaction after receiving injection; or
-
feeling weak or tired, body aches.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Warnings
Tell your doctor if you use other medicines or have other medical conditions or allergies.
Before taking this medicine
Tell your doctor if you have or have ever had:
-
unusual bleeding, any bleeding that will not stop;
-
hepatitis B or C;
-
if you drink large amounts of alcohol; or
-
cirrhosis or other liver disease.
Hemgenix (126-130 kg) is not intended for use by women.
How is Hemgenix (126-130 kg) given?
Your doctor will perform medical tests before starting treatment with Hemgenix (126-130 kg) to make sure is the right treatment for you.
Hemgenix (126-130 kg) is injected into a vein by a healthcare provider.
You will be watched during and for at least 3 hours after the infusion to make sure you do not have a reaction.
Doses are based on weight. Your dose may change if you gain or lose weight.
You will need weekly blood tests to check your liver function for 3 months after treatment.
You may be prescribed other medications to help treat abnormal liver function tests. Keep taking these medicines for as long as your doctor has prescribed.
You may need other medical tests for a longer period of time if you have certain conditions or if you have certain side effects.
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your Hemgenix (126-130 kg).
What happens if I overdose?
In a medical setting an overdose would be treated quickly.
What should I avoid after receiving Hemgenix (126-130 kg)?
Do not donate blood, organs, tissues, or cells for transplantation after receiving Hemgenix (126-130 kg).
What other drugs will affect Hemgenix (126-130 kg)?
Other drugs may affect Hemgenix (126-130 kg), including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Related/similar drugs
Idelvion, Beqvez, BeneFix, NovoSeven RT, coagulation factor ix, Alprolix, Sevenfact
Popular FAQ
Why is Hemgenix the most expensive drug in the world?
More about Hemgenix (etranacogene dezaparvovec)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
Patient resources
- Hemgenix drug information
- Hemgenix (101-105 kg)
- Hemgenix (106-110 kg)
- Hemgenix (111-115 kg)
- Hemgenix (116-120 kg)
Professional resources
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2024 Cerner Multum, Inc. Version: 1.01.